This is the talk page for discussing improvements to the Drug development article. This is not a forum for general discussion of the article's subject. |
Article policies |
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
I need this for my homework but i can't understand the language being used. Please help me!!
We've been preparing for some time now a 'biological toolbox,'" said Moore. "In this new process the enzymes become the tools to do the synthesis." [1] Brian Pearson 02:38, 5 September 2007 (UTC)Reply
Can I prevail on anyone to write sections about the drug development phases in clinical research? Is this found elsewhere on WP?--Dr.michael.benjamin 07:03, 22 October 2007 (UTC)Reply
Lead optimization is redirected to this article but the term is not even mentioned. Should lead optimization really be redirected here? pgr94 (talk) 11:14, 1 October 2008 (UTC)Reply
The cost section is outdated. Does anyone have any objections to it being revised? Additionally does anyone know where more data can be obtained for post-2006? StarsTrainsAndRandomThings (talk) 15:10, 28 April 2009 (UTC)Reply
I got something in German from the Buko. They state that the development would cost somewhere between 125 and 250mio$. And they make clear that it should be really 400mio $ instead of the 800mio $ including the opportunity costs (because you're developing something which will be sold as well). Oh, and that the Scientists calculating the former costs are mainly paid from the pharma industry. Ah, here Collier R., CMAJ. 2009 Feb 3;180(3):279-80., Drug development cost estimates hard to swallow., PMID 19188620 we are. But he does also not give any new number. Light and Warburton, 2005, Extraordinary claims require extraordinary evidence, Journal of Health Economics Volume 24, Issue 5, September 2005, Pages 1030-1033 states 6 main critique points to the original study. But the original author is then trying to argue against that. While Adams CP and Brantner VV., Health Aff (Millwood). 2006 Mar-Apr;25(2):420-8. Estimating the cost of new drug development: is it really 802 million dollars? PMID 16522582 estimates costs to vary from around 500 million dollars to more than 2,000 million dollars. Can someone maybe read through a bit of that and pack it into a nice and objective paragraph now? With so much subjective numbers I unfortunately lost my will and time to write something objective. Thanks ;-) Peterthewall (talk) 10:50, 19 January 2010 (UTC)Reply
Article should mention the FDA Investigational New Drug (IND) as being required to start clinical trials. Rod57 (talk) 00:07, 23 November 2010 (UTC)Reply
Suspect original text (uncited) was very old - It doesn't seem to reflect current usage and practice and seems to need a rewrite or restructure. - Rod57 (talk) 09:57, 13 May 2011 (UTC)Reply
The content regarding the regulatory process only mentions the US regulations. the sidebar mentions the US specifically. I know that the FDA is something of a trendsetter in development and regulation, but that doesnt mean that only mentioning the US regulatory process (and estimates, e.g. diMasi) with a cursory mention of european initiatives at the end, is sufficiently globalized. -- UseTheCommandLine (talk) 19:41, 5 February 2013 (UTC)Reply
Hello fellow Wikipedians,
I have just modified one external link on Drug development. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
When you have finished reviewing my changes, please set the checked parameter below to trueorfailed to let others know (documentation at {{Sourcecheck}}
).
Y An editor has reviewed this edit and fixed any errors that were found.
Cheers.—InternetArchiveBot (Report bug) 04:01, 17 December 2016 (UTC)Reply
It would be interesting to include if we could find any stats on how long drugs take to develop (median, fast and slow outliers, different types, etc.). I'm interested in the whole process, from identification of a new target to new drug sales (and maybe even generic availability?) -- Beland (talk) 00:57, 2 July 2018 (UTC)Reply
This article was the subject of a Wiki Education Foundation-supported course assignment, between 6 September 2023 and 14 December 2023. Further details are available on the course page. Student editor(s): ChrisMisu (article contribs).
— Assignment last updated by ChrisMisu (talk) 00:10, 10 November 2023 (UTC)Reply